» Articles » PMID: 24790821

Patient Perceptions and Expectations Regarding Imaging for Metastatic Disease in Early Stage Breast Cancer

Overview
Journal Springerplus
Date 2014 May 3
PMID 24790821
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The probability of detecting radiologically evident metastatic disease in asymptomatic women with newly diagnosed operable breast cancer is low. Despite the recommendations of most practice guidelines imaging is still frequently performed. Relatively little is known about what patients believe is important when it comes to radiologic staging.

Methods: Patients with early stage breast cancer who had completed their definitive breast surgery were surveyed about their personal experiences, perceptions, and expectations on the issue of perioperative imaging for distant metastatic disease.

Results: Over a 3 month period, 245 women with primary operable breast cancer completed the questionnaire (87.0% response rate) and 80.8% indicated having had at least one imaging test for distant metastatic disease. These were either of the thorax (72.2%), abdomen (55.9%) or skeleton (65.3%) with a total of 701 imaging tests (average of 3.5 tests per patient imaged) performed. Overall, 57.1% indicated that they would want imaging done if the chance of detecting metastases was ≤10%. Although 80.0% of patients indicated that, "doing whatever their doctor recommended" was important to them, 70.4% also noted that they would be uncomfortable if their physician did not order imaging, even if this was in keeping with practice guidelines.

Conclusions: Most patients with early stage breast cancer recall having imaging tests for distant metastases. Given the choice, most would prefer having imaging performed, even if this is not in line with current guidelines. If patient expectations are, in part, driving excessive imaging, new strategies addressing this are required.

Citing Articles

Need for Staging Investigations in Newly Diagnosed Breast Cancer: Establishing Local Guidelines for Radiological Staging in Bahrain.

Alkazaz A, Ali N, Salman A, Almahari S, Altaei T, Albati W Eur J Breast Health. 2024; 20(2):136-140.

PMID: 38571694 PMC: 10985570. DOI: 10.4274/ejbh.galenos.2024.2024-1-6.


Staging for Breast Cancer: A Nationwide Survey about Adherence to Guidelines in German Breast Centers.

Jannes M, Konig A, Kolben M, Fridrich C, Kirn V Breast Care (Basel). 2022; 17(3):316-320.

PMID: 35957950 PMC: 9247493. DOI: 10.1159/000521967.


The Rethinking Clinical Trials (REaCT) Program. A Canadian-Led Pragmatic Trials Program: Strategies for Integrating Knowledge Users into Trial Design.

Saunders D, Liu M, Vandermeer L, Alzahrani M, Hutton B, Clemons M Curr Oncol. 2021; 28(5):3959-3977.

PMID: 34677255 PMC: 8534460. DOI: 10.3390/curroncol28050337.


Expanded criteria for pretreatment staging CT in breast cancer.

Roszkowski N, Lam S, Copson E, Cutress R, Oeppen R BJS Open. 2021; 5(2).

PMID: 33715004 PMC: 7955978. DOI: 10.1093/bjsopen/zraa006.


Usefulness of staging chest-CT in patients with operable breast cancer.

Hong J, Goo J, Moon H, Chang J, Lee J, Park C PLoS One. 2021; 16(2):e0246563.

PMID: 33571270 PMC: 7877605. DOI: 10.1371/journal.pone.0246563.


References
1.
Crivello M, Ruth K, Sigurdson E, Egleston B, Evers K, Wong Y . Advanced imaging modalities in early stage breast cancer: preoperative use in the United States Medicare population. Ann Surg Oncol. 2012; 20(1):102-10. PMC: 3923372. DOI: 10.1245/s10434-012-2571-4. View

2.
Myers R, Johnston M, Pritchard K, Levine M, Oliver T . Baseline staging tests in primary breast cancer: a practice guideline. CMAJ. 2001; 164(10):1439-44. PMC: 81070. View

3.
Ravaioli A, Tassinari D, Pasini G, Polselli A, Papi M, Fattori P . Staging of breast cancer: what standards should be used in research and clinical practice?. Ann Oncol. 1998; 9(11):1173-7. DOI: 10.1023/a:1008483806113. View

4.
Morris P, OConnor M, ORafferty C, Sheikh R, Gray J, McDermott R . The excessive cost of baseline diagnostic imaging in early breast cancer. Ir Med J. 2009; 102(5):149-52. View

5.
Gerber B, Seitz E, Muller H, Krause A, Reimer T, Kundt G . Perioperative screening for metastatic disease is not indicated in patients with primary breast cancer and no clinical signs of tumor spread. Breast Cancer Res Treat. 2003; 82(1):29-37. DOI: 10.1023/B:BREA.0000003917.05413.ac. View